Company profile for Kumquat Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The objective of Kumquat is to pioneer novel therapeutic interventions aimed at delivering enduring and transformative advantages for individuals afflicted with cancer. Within Kumquat, our primary emphasis lies in the translation of pioneering scientific advancements into forefront therapeutic modalities. Kumquat amalgamates an adept team alongside a distinguished scientific progenitor, boasting a verified history of pioneerin...
The objective of Kumquat is to pioneer novel therapeutic interventions aimed at delivering enduring and transformative advantages for individuals afflicted with cancer. Within Kumquat, our primary emphasis lies in the translation of pioneering scientific advancements into forefront therapeutic modalities. Kumquat amalgamates an adept team alongside a distinguished scientific progenitor, boasting a verified history of pioneering endeavors in the discovery and advancement of oncological pharmaceuticals.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Ste. 120., San Diego, CA 92121
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.indianpharmapost.com/news/bayer-and-kumquat-initiate-phase-i-study-with-kras-g12d-inhibitor-in-patients-with-kras-mutated-tumors-17975

INDPHARMAPOST
10 Oct 2025

https://www.bayer.com/media/en-us/bayer-and-kumquat-biosciences-enter-global-exclusive-license-and-collaboration-in-precision-oncology/

PRESS RELEASE
12 Aug 2025

https://www.fiercebiotech.com/biotech/takeda-inks-sweet-12b-deal-kumquat-immuno-oncology-program

Gabrielle Masson FIERCE BIOTECH
17 Apr 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty